Management of Cannabis-Induced Bradycardia
Cannabis-induced bradycardia should be managed by first identifying and removing the offending agent (cannabis), followed by supportive care with close monitoring, and reserving temporary pacing only for patients with hemodynamically significant symptoms that persist despite conservative measures.
Initial Assessment and Identification
The critical first step is establishing the temporal relationship between cannabis use and bradycardia onset. Cannabis can cause severe bradycardia through its action on adenosine receptors and increased parasympathetic tone, particularly with chronic heavy use 1, 2, 3. Case reports document sinus pauses as long as 13.8-16 seconds and complete heart block following cannabis exposure 4, 5, 2, 3.
Key clinical features to identify:
- Timing of cannabis use relative to symptom onset (typically occurs shortly after consumption)
- Pattern of use (acute vs. chronic): acute use typically causes tachycardia, while chronic heavy use paradoxically increases parasympathetic activity and causes bradycardia 2
- Associated symptoms: syncope, presyncope, palpitations, chest pain, or dizziness 4, 5, 2
- Specific arrhythmias documented include third-degree AV block, sinus arrest, ventricular asystole, and symptomatic bradycardia 6
Acute Management Algorithm
1. Immediate Cessation and Supportive Care (First-Line)
Most cannabis-induced bradycardia resolves spontaneously within 24 hours after discontinuation 4. The natural history favors conservative management:
- Discontinue cannabis immediately
- Continuous cardiac monitoring
- Assess hemodynamic stability (blood pressure, end-organ perfusion)
- Rule out other reversible causes (metabolic abnormalities, endocrine dysfunction, medications) 7
2. Pharmacologic Intervention (For Symptomatic Patients)
If bradycardia persists with hemodynamic compromise:
- IV isoprenaline has been successfully used in documented cases 4
- Consider atropine for symptomatic bradycardia
- Analgesic/anxiolytic agents for conscious patients if transcutaneous pacing is needed 7
3. Temporary Pacing (Reserved for Severe Cases)
Transcutaneous pacing preparation may be considered for patients at risk for developing severe bradycardia 7. However, temporary transvenous pacing should be avoided in mildly to moderately symptomatic patients due to high complication risks that outweigh benefits, particularly when episodes are intermittent without hemodynamic compromise 7.
When NOT to Pace
Permanent pacing is contraindicated in cannabis-induced bradycardia because 7:
- The bradycardia is secondary to a reversible extrinsic cause (cannabis)
- Symptoms resolve with cannabis cessation
- This represents physiologically elevated parasympathetic tone, not intrinsic sinus node pathology
The guideline explicitly states permanent pacing should not be performed when bradycardia is secondary to physiologically elevated parasympathetic tone or when symptoms occur in the absence of documented bradycardia 7.
Risk Stratification
Higher risk patients requiring closer monitoring:
- Those with underlying cardiac disease, channelopathies, structural heart disease, or prior myocardial infarction 8
- Young males (most commonly affected demographic) 5, 6
- Heavy chronic users (≥5 cannabis cigarettes daily) 2
- Patients with documented cardiac arrest or life-threatening arrhythmias (8 cases of cardiac arrest reported, 5 fatal) 6
Long-Term Management
- Mandatory cannabis cessation counseling - this is the definitive treatment
- Follow-up monitoring to ensure resolution after cessation
- In rare cases of recurrent syncope with high trauma risk despite cessation, pacemaker implantation may be considered only after documented persistent bradycardia 2
- Patient education on cardiovascular risks, especially for those with cardiac risk factors 6
Critical Pitfalls to Avoid
- Do not implant permanent pacemakers acutely - wait for cannabis clearance and reassess
- Do not assume all bradycardia in cannabis users is benign - complete heart block and asystole can occur 4, 5, 3
- Do not overlook cannabis use in young patients with unexplained arrhythmias - specifically inquire about acute and chronic use 6
- Do not use temporary transvenous pacing routinely - complications outweigh benefits in most cases 7
The evidence consistently shows that cannabis-induced bradycardia, while potentially severe and life-threatening, typically resolves with cessation and supportive care, making aggressive interventions like permanent pacing inappropriate 4, 5, 2, 3.